Home › Kidney Cancer (Renal Cell Carcinoma) › Nevada › Reno
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Reno, NV
3 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Reno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Saint Mary's Regional Medical Center, Reno
- Carson Tahoe Regional Medical Center, Carson City · 25 mi away
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
RecruitingPhase 2
- Renown Regional Medical Center, Reno
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Renown Regional Medical Center, Reno
- Saint Mary's Regional Medical Center, Reno
- Radiation Oncology Associates, Reno
- and 1 more
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX34 studies
- New York City, NY29 studies
- St. Louis, MO25 studies
- Dallas, TX24 studies
- Nashville, TN24 studies
- Los Angeles, CA22 studies
- Boston, MA16 studies
- Philadelphia, PA16 studies
- Queens, NY16 studies
- Pittsburgh, PA15 studies
- Baldwin Park, CA15 studies
- Edison, NJ14 studies
Other studies in Reno
- Non-Small Cell Lung Cancer16 studies
- Breast Cancer15 studies
- Lung Cancer9 studies
- Geographic Atrophy8 studies
- Macular Degeneration7 studies
- Cancer (all types)7 studies
- Ovarian Cancer6 studies
- Pancreatic Cancer5 studies
- Metastatic Cancer5 studies
- Colon Cancer5 studies
- Colorectal Cancer5 studies
- Rectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.